Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Anushua Sinha, MD (she/her/hers)

Director
Merck & Co., Inc., Rahway, NJ, USA
Rahway, NJ, United States

Anushua is a Clinical Director at Merck & Co., where she is the Product Development Team Lead for clesrovimab, an investigational anti-RSV preventative monoclonal antibody. Anushua came to Merck in 2016 from Rutgers University, where she was on the faculty of both the Rutgers School of Public Health and Rutgers New Jersey Medical School. She also served as infectious disease attending physician at The University Hospital, Newark NJ, and continued to see outpatients there on a pro bono basis until 2021. She completed her clinical training at Harvard Medical School, Massachusetts General Hospital, and the Brigham and Women’s Hospital. She completed her research training at the Channing Laboratory and the Harvard School of Public Health.

Disclosure information not submitted.

Presentation(s):